Skip to main content
Clinical Trials/ACTRN12617000332325
ACTRN12617000332325
Completed
未知

An evaluation to investigate the impact of the New Medicine Support Service on adherence to newly prescribed medicines

PS MedicineWise0 sites847 target enrollmentMarch 3, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Medicine adherence
Sponsor
PS MedicineWise
Enrollment
847
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 3, 2017
End Date
December 31, 2018
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
PS MedicineWise

Eligibility Criteria

Inclusion Criteria

  • To be included in the study patients must meet the following criteria:
  • \* Be aged 18 years or above;
  • \* Be a Medicare and/or Department of Veterans affairs (DVA) card holder;
  • \* Be living at home in a community setting;
  • \* Be on a newly prescribed medicine for one of the following conditions:
  • –Asthma and other lung conditions such as COPD
  • –Conditions requiring antiplatelet / anticoagulant therapy
  • –Depression
  • –Dyslipidaemia
  • –Hypertension

Exclusion Criteria

  • \-Patient cannot communicate sufficiently in English.
  • \-Patients of public or private hospitals, day hospital facilities, transitional care facilities or to residents of an Aged Care facility.
  • \- Patients who are collecting medicine where the only change from the previous medicine involves a dosage, strength, brand or formulation change(s).

Outcomes

Primary Outcomes

Not specified

Similar Trials